Literature DB >> 18084947

First-line chemotherapy in advanced pancreatic cancer.

U Pelzer1.   

Abstract

This chapter focuses on first-line therapy in inoperable pancreatic cancer.

Entities:  

Mesh：

Year:  2008        PMID： 18084947     DOI： 10.1007/978-3-540-71279-4_7

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN： 0080-0015


  3 in total

1.  Blood group determinates incidence for pancreatic cancer in Germany.

Authors:  U Pelzer; F Klein; M Bahra; M Sinn; B Dörken; P Neuhaus; O Meyer; H Riess
Journal:  Front Physiol       Date:  2013-05-24       Impact factor: 4.566

2.  Value of carbohydrate antigen 19-9 in predicting response and therapy control in patients with metastatic pancreatic cancer undergoing first-line therapy.

Authors:  Uwe Pelzer; Andreas Hilbig; Marianne Sinn; Jens Stieler; Marcus Bahra; Bernd Dörken; Hanno Riess
Journal:  Front Oncol       Date:  2013-06-14       Impact factor: 6.244

3.  Intensified chemotherapy and simultaneous treatment with heparin in outpatients with pancreatic cancer - the CONKO 004 pilot trial.

Authors:  Uwe Pelzer; Andreas Hilbig; Jens M Stieler; Marcus Bahra; Marianne Sinn; Bernhard Gebauer; Bernd Dörken; Hanno Riess
Journal:  BMC Cancer       Date:  2014-03-19       Impact factor: 4.430
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.